Filing Flows

Filing Flows › Materials › Cibus (CBUS)

Cibus (CBUS) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Cibus (CBUS) Q2 2026 earnings results →

Q2 2026 Revenue up 6% year over year to $994K

Cibus made $994K in Q2 2026 (+6% Y/Y). Operating margin n/m, net loss $22.1M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$994K
Year over year+6%
Operating marginn/m
Net earnings−$22.1M
Operating cash flow−$9.4M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $1.0M in Q2 2026, up 7% year over year and down 41% from the previous quarter.

Operating costs exceeded revenue by $12.9M, an operating margin of -1300.3%. Total costs fell 26% while revenue rose 7%. The quarter ended with a net loss of $22.1M, wider than the previous quarter's $21.2M loss.

Operating cash flow was −$9.4M. Non-cash charges added back $1.2M of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items added $10.1M. Capital expenditures of −$42K exceeded it, leaving free cash flow of −$9.4M.

Quarterly history

Cibus revenue by quarterCibus revenue by quarter$1.2MQ4 2024$1.0MQ1 2025$933KQ2 2025$615KQ3 2025$1.1MQ4 2025$1.7MQ1 2026$994KQ2 2026
Cibus net earnings by quarterCibus net earnings by quarter−$25.8MQ4 2024−$49.4MQ1 2025−$26.6MQ2 2025−$24.3MQ3 2025−$31.9MQ4 2025−$21.2MQ1 2026−$22.1MQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 13, 2026$994K+6%n/m−$22.1M−$9.4M
Q1 202610-QMay 14, 2026$1.7M+63%-721.0%−$21.2M−$11.5M
Q4 202510-KMar 17, 2026$1.1M-13%n/m−$31.9M−$13.4M
Q3 202510-QNov 13, 2025$615K-63%n/m−$24.3M−$11.7M
Q2 202510-QAug 14, 2025$933K+11%n/m−$26.6M−$13.6M
Q1 202510-QMay 8, 2025$1.0M+90%n/m−$49.4M−$11.8M
Q4 202410-KMar 20, 2025$1.2M+10%n/m−$25.8M−$14.0M

Charts

Cibus: revenue growth, year over year and quarter over quarterCibus: revenue growth, year over year and quarter over quarterY/YQ/Q+10%Q4 2024+90%-15%Q1 2025+11%-10%Q2 2025-63%-34%Q3 2025-13%+72%Q4 2025+63%+59%Q1 2026+6%-41%Q2 2026
Latest (Q2 2026): Y/Y +6%, Q/Q -41%.
Cibus: where the cash came from (+) and went (−), TTM to Q2 2026Cibus: where the cash came from (+) and went (−), TTM to Q2 2026Operating cash flow−$46.1MOther financing$31.5MCash drawn (+) / kept (−)$16.0MNet borrowing (+) / repaid (−)−$1.1MCapital spending−$267KTaxes on employees’ shares−$218KOther investing$43KExchange rates−$9K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Cibus: profit against cash, quarter by quarterCibus: profit against cash, quarter by quarterNet incomeOperating cash flow−$201M−$13.5MQ3 2024−$25.8M−$14.0MQ4 2024−$49.4M−$11.8MQ1 2025−$26.6M−$13.6MQ2 2025−$24.3M−$11.7MQ3 2025−$31.9M−$13.4MQ4 2025−$21.2M−$11.5MQ1 2026−$22.1M−$9.4MQ2 2026
Latest (Q2 2026): Net income −$22.1M, Operating cash flow −$9.4M.
Cibus: diluted shares by fiscal year (split-adjusted)Cibus: diluted shares by fiscal year (split-adjusted)68MFY202075MFY202192MFY202221MFY202346MFY202446MFY2025
-32.5% since FY2020: buybacks shrank the count; earlier years scaled for the 2-for-1 split before FY2025.
Cibus: long-term debt falling due (FY2025)Cibus: long-term debt falling due (FY2025)$459K2026$89K2027$11K2028
Cash $9.9M, short-term investments —, long-term debt $528K at 2025-12-31.
Cibus in its industry: growth against margin (7 companies, SIC 2870)Cibus in its industry: growth against margin (7 companies, SIC 2870)revenue growth, year over year →↑ operating marginmedian +1%median -2%MOSCFSMGUANAVDSNESCBUS (+6%, -100%)
Agricultural Chemicals; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Cibus

COMPANY OVERVIEW Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment. Cibus produces these edited plant traits by a unique process that is endeavoring to change the scale and speed of plant breeding for many major agricultural crops. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ ( RTDS ® ). This system allows Cibus to edit gene targets that are the basis of novel traits that can be integrated into Cibus’ customers’ best or elite seed genetics in as

In its own words, from its 10-K, filed Mar 17, 2026.

Cibus against its Agricultural Chemicals peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +6% against the peers' median +1%.

CompanyQuarterRevenueY/YOp. margin
CBUS CibusQ2 2026$994K+6%n/m
MOS MosaicQ3 2026$3.1B-10%-3.1%
CF CF Industries HoldingsQ3 2026$1.9B+12%37.7%
SMG Scotts Miracle-GroQ3 FY26$1.2B+1%14.5%
UAN CVR Partners, LPQ3 2026$146M-11%-2.5%
AVD American VanguardQ2 2026$117M-10%-0.3%
SNES SenesTechQ2 2026$770K+23%-241.8%

Source: Cibus 10-Q on SEC EDGAR · CIK 1705843 · Agricultural Chemicals

13F: who owns CBUS and who is buying

Largest holders of CBUS (13F)Largest holders of CBUS (13F)FMR LLC$15.7MVanguard Capital Management LLC$3.2MVanguard Group$2.2MVantage Consulting Group$2.0MTransce3nd, LLC$1.0MUnited Capital Financial Advisors…$789KGeode Capital Management, LLC$724KBlackRock$675KCertior Financial Group, LLC$563KCoppell Advisory Solutions LLC$465K
Funds' net buying of CBUS by quarter (13F)Funds' net buying of CBUS by quarter (13F)−$12.3M2024-09−$3.1M2024-12$4.9M2025-03$819K2025-06−$1.6M2025-09$1.1M2025-12$302K2026-03−$4.8M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on CBUS

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare CBUS with

中文版:Cibus(CBUS)财报

Español · Français